New drug combo aims to knock out hepatitis b virus
NCT ID NCT07245953
Summary
This study is testing whether two new injections, called HT-101 and HT-102, can help control chronic Hepatitis B. It will involve 60 patients who already have the virus to see if the treatment can reduce or eliminate detectable virus in their blood. The main goal is to find the best treatment strategy and check the long-term safety and effectiveness of the drug combination.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Ditan Hospital Capital Medical University
Beijing, Beijing Municipality, 100015, China
-
Guangzhou Eighth People's Hospital, Guangzhou Medical University
Guangzhou, Guangdong, 510440, China
-
Henan Infectious Diseases Hospital , The Sixth People's Hospital of Zhengzhou
Zhengzhou, Henan, 450000, China
-
Mengchao Hepatobiliary Hospital of Fujian Medical University
Fuzhou, Fujian, 350028, China
-
Nanchang Ninth Hospital
Nanchang, Jiangxi, 330022, China
-
Nanfang Hospital
Guangzhou, Guangdong, 510515, China
-
Qingyuan People's Hospital
Qingyuan, Guangdong, 511518, China
-
Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine
Nanning, Guangxi, 530011, China
-
Shanghai Public Health Clinical Center
Shanghai, Shanghai Municipality, 200083, China
-
Sichuan Provincial People's Hospital
Chengdu, Sichuan, 610072, China
-
The Second Hospital of Nanjing
Nanjing, Jiangsu, 210003, China
-
Zhenjiang Third People's Hospital (Zhenjiang Infectious Diseases Hospital)
Zhenjiang, Jiangsu, 212021, China
Conditions
Explore the condition pages connected to this study.